Sernova (FRA:PSH) Net Issuance of Preferred Stock

: €0.00 Mil (TTM As of Jan. 2023)

View and export this data going back to 2014. Start your Free Trial

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Sernova's net issuance of preferred for the three months ended in Jan. 2023 was €0.00 Mil. The number is 0, which means that Sernova has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Sernova's net issuance of preferred for the trailing twelve months (TTM) ended in Jan. 2023 was €0.00 Mil.

Sernova Net Issuance of Preferred Stock Historical Data

The historical data trend for Sernova's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Net Issuance of Preferred Stock

Sernova Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Net Issuance of Preferred Stock																-	-	-	-	-

Sernova Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Sernova Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Sernova's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (FRA:PSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (FRA:PSH) Headlines

No Headlines